Table 3. Meta-analysis of the association between ZFAS1 expression and clinicopathological parameters.
| Clinicopathological parameters | Studies (n) | Total cases | OR (95% CI) | P-value | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
| I2 (%) | Ph | Model | |||||
| Gender (Male vs. Female) | 7 | 701 | 0.98 (0.73–1.33) | 0.91 | 15 | 0.32 | Fixed |
| Tumor size (≥ 5 cm vs. < 5 cm) | 5 | 539 | 1.41 (1.00–1.99) | 0.05 | 24 | 0.26 | Fixed |
| Vascular invasion (Yes vs. No) | 3 | 280 | 2.26 (1.36–3.78) | 0.002 | 0 | 0.52 | Fixed |
| Lymph node metastasis (Yes vs. No) | 6 | 613 | 2.98 (2.12–4.19) | < 0.001 | 11 | 0.35 | Fixed |
| TNM stage ( III–IV vs. I–II) | 7 | 679 | 3.00 (2.18–4.12) | < 0.001 | 2 | 0.41 | Fixed |